Evidence map›Paper›PMID 37045454›Full record

ArticleNeurosciences (Riyadh, Saudi Arabia)2023

The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia.

Ahmed N Alshammari, Khalid A Alshammari, Salman N Alshammari, Saad Y Aldhaifi, Abdulaziz S Alqahtani

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurosciences (Riyadh, Saudi Arabia), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ahmed N AlshammariFrom the Internal Medicine Department (Alshammari A), College of Medicine, College of Medicine (Alshammari K, Alshammari S, Aldhaifi S), From Ear, Nose, and Throat (ENT) Department (Alqahtani), College of Medicine, University of Hail, Hail, Kingdom of Saudi Arabia.
Khalid A AlshammariFrom the Internal Medicine Department (Alshammari A), College of Medicine, College of Medicine (Alshammari K, Alshammari S, Aldhaifi S), From Ear, Nose, and Throat (ENT) Department (Alqahtani), College of Medicine, University of Hail, Hail, Kingdom of Saudi Arabia.
Salman N AlshammariFrom the Internal Medicine Department (Alshammari A), College of Medicine, College of Medicine (Alshammari K, Alshammari S, Aldhaifi S), From Ear, Nose, and Throat (ENT) Department (Alqahtani), College of Medicine, University of Hail, Hail, Kingdom of Saudi Arabia.
Saad Y AldhaifiFrom the Internal Medicine Department (Alshammari A), College of Medicine, College of Medicine (Alshammari K, Alshammari S, Aldhaifi S), From Ear, Nose, and Throat (ENT) Department (Alqahtani), College of Medicine, University of Hail, Hail, Kingdom of Saudi Arabia.
Abdulaziz S AlqahtaniFrom the Internal Medicine Department (Alshammari A), College of Medicine, College of Medicine (Alshammari K, Alshammari S, Aldhaifi S), From Ear, Nose, and Throat (ENT) Department (Alqahtani), College of Medicine, University of Hail, Hail, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate, in a Saudi Arabian context, how the COVID-19 pandemic psychologically impacted persons with multiple sclerosis (PwMS).

methodsA cross-sectional study was undertaken during the period from October 2021 to March 2022. 738 participants resident in the Kingdom of Saudi Arabia (KSA) completed a self-administered online questionnaire. The research focused on persons diagnosed with MS.

resultsParticipant ages spanned from 18 to over 55. The mean was 36.1±12.9 years old. Four hundred eighty-nine (66.3%) of the 738 participants were female. Two hundred sixty-four (35.8%) were single. Four hundred twelve (55.8%) were married. Six hundred eighty-five (92.8%) had received a COVID-19 vaccine. Regarding MS duration, 117 (15.9%) had been diagnosed for less than 2 years, 171 (23.2%) for 2-5 years, while 251 (34%) had the condition for 10 or more years. Regarding psychological health, 11.2% of participants complained of minimal/no depression, 33.3% of mild depression, 28.3% of moderate depression, and 27.1% of moderately severe to severe depression symptoms. Concerning anxiety, 17.2% of participants reported minimal anxiety, 36.9% mild, 23.3% moderate, while 22.6% suffered from severe anxiety symptoms.

conclusionA high prevalence of depression and anxiety was found, along with high prevalence of co-occurrence of these disorders among PwMS.

Indexed as

COVID-19Multiple SclerosisAdultAnxietyCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansMaleMiddle AgedPandemicsSaudi ArabiaYoung AdultCOVID-19 Vaccines

Identifiers

PMID37045454
PMCPMC10155471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.